Ładuje się......
Metformin Attenuates Liver Fat Content: Finding from Schizophrenia Patients with Olanzapine-induced Weight Gain
OBJECTIVE: This study was performed to evaluate the efficacy of metformin on liver fat content (LFC) in first episode schizophrenia patients with olanzapine-induced weight gain, and the relationship between the change of LFC and the other metabolic indices. METHODS: In a double-blind study, the clin...
Zapisane w:
| Wydane w: | Clin Psychopharmacol Neurosci |
|---|---|
| Główni autorzy: | , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Korean College of Neuropsychopharmacology
2020
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7006974/ https://ncbi.nlm.nih.gov/pubmed/31958907 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9758/cpn.2020.18.1.67 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|